CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders

Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 9 Issue: 1, March

Commentary [Research Highlights]

Volume:9   Issue: 1
Pp: 1-1
Stephen D. Skaper
DOI: 10.2174/187152710790966669
Published on: 01 March, 2012

Editorial [Hot topic: Pharmacotherapies for Alcoholism: The Old and the New (Guest Editor: M. Foster Olive)]

Volume:9   Issue: 1
Pp: 2-4
M. Foster Olive
DOI: 10.2174/187152710790966722
Published on: 01 March, 2012

Disulfiram: An Old Therapeutic with New Applications

Volume:9   Issue: 1
Pp: 5-12
Kelly S. Barth and Robert J. Malcolm
DOI: 10.2174/187152710790966678
Published on: 01 March, 2012

Naltrexone for the Treatment of Alcoholism: Clinical Findings, Mechanisms of Action, and Pharmacogenetics

Volume:9   Issue: 1
Pp: 13-22
Lara A. Ray, Pauline F. Chin and Karen Miotto
DOI: 10.2174/187152710790966704
Published on: 01 March, 2012

Acamprosate: A Prototypic Neuromodulator in the Treatment of Alcohol Dependence

Volume:9   Issue: 1
Pp: 23-32
Barbara J. Mason and Charles J. Heyser
DOI: 10.2174/187152710790966641
Published on: 01 March, 2012

Effectiveness and Safety of Baclofen in the Treatment of Alcohol Dependent Patients

Volume:9   Issue: 1
Pp: 33-44
Lorenzo Leggio, James C. Garbutt and Giovanni Addolorato
DOI: 10.2174/187152710790966614
Published on: 01 March, 2012

The Role of Topiramate and Other Anticonvulsants in the Treatment of Alcohol Dependence: A Clinical Review

Volume:9   Issue: 1
Pp: 45-49
Avinash De Sousa
DOI: 10.2174/187152710790966696
Published on: 01 March, 2012

Aripiprazole: A Drug with a Novel Mechanism of Action and Possible Efficacy for Alcohol Dependence

Volume:9   Issue: 1
Pp: 50-54
Derick E. Vergne and Raymond F. Anton
DOI: 10.2174/187152710790966731
Published on: 01 March, 2012

Blockade of the Cannabinoid CB1 Receptor and Alcohol Dependence: Preclinical Evidence and Preliminary Clinical Data

Volume:9   Issue: 1
Pp: 55-59
Paola Maccioni, Giancarlo Colombo and Mauro A.M. Carai
DOI: 10.2174/187152710790966623
Published on: 01 March, 2012

Neuronal Nicotinic Acetylcholine Receptors as Pharmacotherapeutic Targets for the Treatment of Alcohol Use Disorders

Volume:9   Issue: 1
Pp: 60-76
S. Chatterjee and S. E. Bartlett
DOI: 10.2174/187152710790966597
Published on: 01 March, 2012

Pre-Clinical Evidence that Corticotropin-Releasing Factor (CRF) Receptor Antagonists are Promising Targets for Pharmacological Treatment of Alcoholism

Volume:9   Issue: 1
Pp: 77-86
Emily G. Lowery and Todd E. Thiele
DOI: 10.2174/187152710790966605
Published on: 01 March, 2012

The Nociceptin/Orphanin FQ System as a Target for Treating Alcoholism

Volume:9   Issue: 1
Pp: 87-93
Niall P. Murphy
DOI: 10.2174/187152710790966713
Published on: 01 March, 2012

TRPC Channels and their Implications for Neurological Diseases

Volume:9   Issue: 1
Pp: 94-104
Senthil Selvaraj, Yuyang Sun and Brij B. Singh
DOI: 10.2174/187152710790966650
Published on: 01 March, 2012

Mitochondrial Metabolism Modulation: A New Therapeutic Approach for Parkinsons Disease

Volume:9   Issue: 1
Pp: 105-119
D. M. Arduino, A. R. Esteves, C. R. Oliveira and S. M. Cardoso
DOI: 10.2174/187152710790966687
Published on: 01 March, 2012

Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases

Volume:9   Issue: 1
Pp: 120-127
Sarah Burgess and Valentina Echeverria
DOI: 10.2174/187152710790966632
Published on: 01 March, 2012